|
ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs.
We apply new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identify proprietary and related molecules for better patient treatment.
Recent Releases
Jan 20, 2012
ZIOPHARM Oncology Prices Public Offering of Common Stock
Jan 19, 2012
ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
more »
Events
Jan 11, 2012
The 30th Annual J.P. Morgan Healthcare Conference
Dec 14, 2011
The Oppenheimer 22nd Annual Healthcare Conference
more »
| 
